DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION ArticleAshrafian L., Suhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E.EPMA Journal. Том Vol625. 2015.
PHARMACOKINETIC STUDY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN FEMALE PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA ArticleAndrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I.Biology and Medicine. Том Vol7. 2015.
STUDY TO ASSESS SAFETY AND TOLERABILITY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA ArticleAndrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I.Biology and Medicine. Том Vol7. 2015.
